Subsection
Preventative Health & Longevity sits under Family & Lifelong Care . Screening, early detection, and the interventions that extend healthy years.
37 stories
Roughly half of men on BPH drugs see their symptoms return after years of control. The 2026 procedural ladder — UroLift, Rezum, water vapor, PAE, and the newer iTind — has matured into a real set of options that work better than medications and avoid the sexual side effects of traditional surgery.
Medicare launched a GLP-1 pilot in 2026 with a $50 monthly cap that should have expanded access to Wegovy and Zepbound. NPR found on August 30, 2026 that the eligibility criteria exclude the patients with the most serious obesity-related illnesses. Here is who qualifies, who does not, and what to do if you are excluded.
Iron deficiency can cause exhaustion, brain fog, and breathlessness long before anemia shows up. Here is why ferritin testing matters and how to fix it.
Routine vitamin D supplementation for healthy adults lacks strong proof of benefit. Here is who actually needs testing and treatment, and who is wasting money.
The 2026 CDC RSV guidance says adults 75+ and at-risk adults 50–74 should get one dose, and it is not an annual shot. Here is the timing and the group that qualifies this season.
The FDA approved bemotrizinol in June 2026, the first new sunscreen active ingredient in more than two decades. Here is what it does, how it differs from current filters, and when it will reach shelves.
Congress and the FTC took aim at pharmacy benefit managers in 2026. Here is what changed, when it takes effect, and how it could lower your prescription costs.
Enlarged prostate and prostate cancer share a name and a location, but they are not the same condition. Here is what 2025–2026 urology guidance says about BPH, screening, and when to worry.
Acid reflux affects roughly 20% of U.S. adults weekly. For many, PPIs are overprescribed and carry long-term risks. Here is the evidence-based path to relief without lifelong medication.
Prediabetes affects roughly 96 million U.S. adults, but GLP-1s are not the only answer. Here is what 2025-2026 evidence says about lifestyle, metformin, and when drugs fit.
A stubborn reading on medication panics patients. Here is what 2025-2026 evidence says about why pills lag and what actually lowers it.
Beet juice and breathing hacks flood BP threads. Here is what 2025-2026 evidence says about what helps and what is hype.
Unexpected pharmacist interaction calls confuse patients. Here is what 2025-2026 evidence says about why they call and what to do.
The 'did I take it' panic leads to double doses. Here is what 2025-2026 evidence says about memory aids that actually work.
Muscle pain drives many to abandon statins. Here is what 2025-2026 evidence says about real risk, safe switching, and protecting your heart.
Timing and food gut thyroid absorption. Here is what 2025-2026 evidence says about the right window and common mistakes.
Doctor visits are evolving rapidly due to AI and new care models. Discover how to navigate these shifts to ensure you get the best outcomes. 30% of US clinics now use AI.
Why is the search for a new oral cholesterol pill ongoing? While no new drug was approved in 2026, research shows current options can slash LDL-C by 25% ([CLEAR Outcomes](https://www.nejm.org/), 2023).
A drink can turn a safe drug risky. Here is what 2025-2026 evidence says about alcohol and medication interactions to avoid.
Taking BP pills at the wrong time can blunt their benefit. Here is what 2025-2026 evidence says about timing and bedtime dosing.
That third coffee can tip you into panic. Here is what 2025-2026 evidence says about caffeine, anxiety, and your personal limit.
Daily pain pills add up to real organ damage. Here is what 2025-2026 evidence says about safe limits and the hidden risks.
Your thyroid pill can fail if taken with the wrong food. Here is what 2025-2026 evidence says about timing and hidden interactions.
Half of long-term meds go untaken. Here is a practical, pharmacist-backed system to build a routine that works for you or a loved one.
High deductibles leave prescriptions unaffordable. Here are 7 evidence-backed ways to cut drug costs without risking your treatment.
Forgetting a dose or fearing a double dose is common. Here is what 2025-2026 guidance says to do in the moment, calmly and safely.
Statins spark fierce debate online. Here is what 2025-2026 evidence says about real risks, real benefits, and who should take them.
New data shows a 35% increase in Vitamin K deficiency bleeding among infants whose parents decline the shot. Learn why this protection is essential.
In 2025, 23,000 never-smokers were diagnosed with lung cancer in the U.S. Learn the environmental, genetic, and biological factors behind this rising trend.
Yale scientists found a hidden retinal network that regulates light adaptation, affecting over 2.2 billion people with vision issues worldwide (WHO, 2024). Learn its impact on eye health.
GLP-1 receptor agonists treat diabetes, obesity, and cardiovascular risk. We break down how semaglutide and tirzepatide work, who benefits, what they cost, and what the 2026 evidence shows about muscle loss.
Longevity science spent decades on male data. In 2026 the focus finally turns to women's biology, ovarian aging, and healthspan.
Non-adherence is a 300 billion dollar crisis with real harm. Practical, pharmacist-backed ways to take medications as prescribed.
PGx testing is moving mainstream. How a genotype report becomes an actionable counseling moment at the pharmacy.
PGx testing is moving mainstream. How a genotype report becomes an actionable counseling moment at the pharmacy.
Hundreds of millions now ask AI for health advice. How to use ChatGPT and Perplexity without risking your care.
The mRNA platform that powered pandemic response now targets cancer and flu. A status check on the 2026 pipeline.
More from Family & Lifelong Care .
